Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 15 Squamous Cell Carcinoma of Head and Neck 12 Neoplasm Metastasis 12 Prostatic Neoplasms 11 Neoplasms 10 Breast Neoplasms 8 Stomach Neoplasms 7 Recurrence 7 Ovarian Neoplasms 7 Myasthenia Gravis 7 Lung Neoplasms 7 Leukemia, Myeloid, Acute 7 Head and Neck Neoplasms 7 Colorectal Neoplasms 6 Pancreatic Neoplasms 5 Oropharyngeal Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Fatigue 5 Urinary Bladder Neoplasms 4 Mouth Neoplasms 4 Melanoma 4 Fallopian Tube Neoplasms 4 Endometrial Neoplasms 4 Colonic Neoplasms 4 Cholangiocarcinoma 4 Rectal Neoplasms 3 Peritoneal Neoplasms 3 Laryngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 Glioblastoma 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Advanced Solid Cancers × 90 days × Clear all

NCT07290088 2026-04-16

PRL3-zumab

Intra-IMMUSG Pte Ltd

Phase 2/3 Recruiting

Advanced Solid Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡